Skip to main content

Animations

MJFF Publications

6781 - 6790 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2021
  • 2023
  • 2022
  • 2023
  • 2020
  • 2023
  • 2017
  • 2022
  • Summary Details
    OPEN
    Title: The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00896-2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Unique nigral and cortical pathways implicated by epigenomic and transcriptional analyses in rotenone Parkinson’s model
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01049-1
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.abg3092
    Citation Count: 91
  • Summary Details
    OPEN
    Title: A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies
    Journal Name: Annals of Epidemiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.annepidem.2023.04.019
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/pro.4360
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase Inhibitors
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschembio.2c00868
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2020.117157
    Citation Count: 16
  • Summary Details
    OPEN
    Title: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ange.202309306
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.aam9080
    Citation Count: 736
  • Summary Details
    RESTRICTED
    Title: Parkinson's Progression Markers Initiative brain autopsy program
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.017
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.